Raymond James raises Nasdaq stock price target to $111 on earnings

Raymond James raised its price target on Nasdaq OMX Group to $111 from $110 while keeping an Outperform rating, citing continued momentum in first-quarter 2026 results. The firm said Market Services remains healthy and sees limited AI disruption risk, supporting a higher valuation multiple; Nasdaq also posted Q1 EPS of $0.96 versus $0.93 expected and revenue of $2.14 billion versus $1.37 billion consensus. The note is supportive for NDAQ, but the impact is likely limited to the stock and analyst sentiment rather than the broader market.

Analysis

NDAQ remains one of the cleaner “growth-with-quality” stories in market infrastructure, but the next leg is likely to come from multiple expansion rather than fundamental surprise. The key second-order effect is that a durable increase in retail options/equities participation lifts not just transaction revenue, but also pricing power across data, listings, and index licensing—businesses with higher retention and lower cyclicality than market services. That mix shift matters because it can compound EBITDA faster than headline volume growth and makes the stock less exposed to a single macro variable.

The bigger debate is whether the AI-disruption narrative is actually a discounting event or a real risk. If AI improves workflow efficiency for banks, brokers, and asset managers, Nasdaq can be a beneficiary through higher client productivity and more demand for market-data/analytics, not just a target. The real vulnerability is regulatory and competitive: if exchanges start competing harder on fees or if retail engagement normalizes faster than expected over the next 2-3 quarters, the market may have to de-rate the name from a “compounder” multiple toward a more market-sensitive infrastructure multiple.

The valuation setup looks constructive, but consensus may be underpricing the asymmetry around volatility. If options volumes stay elevated into rate-cut speculation or geopolitical shocks, earnings can accelerate because Nasdaq monetizes activity spikes with very little incremental cost. Conversely, if equity breadth broadens away from speculative trading, growth can decelerate without an obvious top-line collapse, which is the most dangerous scenario for the multiple.

The contrarian view is that the stock may be expensive on a normalized basis even if it looks reasonable versus near-term growth. The market is paying for persistence of elevated retail engagement and stable issuance conditions; both can fade quickly. That argues for respecting the name as a high-quality long, but not as a set-and-forget compounder unless the company can keep expanding recurring revenue faster than trading revenue cools.

Key Decisions for Investors

• Maintain a tactical long NDAQ, but size it as a valuation-sensitive compounder, not a core defensive holding; best entry is on any 5-8% pullback over the next 1-2 months if market-services momentum is questioned.
• Express the thesis with a call spread in NDAQ (3-6 month tenor) rather than outright stock if implied volatility remains moderate; upside is tied to multiple expansion and has limited fundamental downside if volumes normalize.
• Pair long NDAQ vs short a more cyclical exchange/market-activity proxy if retail-flow deceleration becomes visible; the trade works if recurring data/index revenue continues to offset weaker trading volumes over the next quarter.
• If you already own the name, take partial profits into any post-earnings strength and re-add only if revenue mix continues shifting toward recurring tech/data revenue; that is the highest-conviction re-rating catalyst.
• Use a downside hedge via short-dated puts if broad market volatility compresses and NDAQ rerates above 30x forward earnings; the risk/reward worsens quickly if activity data rolls over.